Acetaminophen (Paracetamol) Market: by Form (Tablet, Liquid Suspension, Capsule, and Other Forms); by Route of Administration (Oral, Rectal and Intravenous): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Published Date: 15-Nov-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5067 Status : Published

Description

The report covers forecast and analysis for the acetaminophen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the acetaminophen market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the acetaminophen market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the acetaminophen market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the acetaminophen market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new form launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the acetaminophen market on global and regional basis.

The study provides a crucial view on the acetaminophen by segmenting the market based on form, indication, route of administration and region. All the segments of acetaminophen market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Acetaminophen (APAP) is commonly known as paracetamol is a drug used to treat fever (antipyretic) and pain (analgesic). It is classified as mild analgesic and is widely used for relief of mild to moderate intensity pain. For severe type of pain like pain after surgery, cancer pain etc. it is used in combination with opioid drugs. Acetaminophen is used in combination of cold medications to relieve fever in children. Paracetamol is mostly given orally or rectally, but it is also administered via intravenous route.

The demand for acetaminophen market is driven by increasing prevalence of chronic disorders and conditions requiring pain management. Also, it is widely available as an over the counter medicine in many countries and is being used as analgesic for treating mild to moderate pain. Increasing use of acetaminophen drives the market growth. However, availability of large number of generics and intense competition may restrain the market growth. Emerging markets with increasing geriatric population base are expected to bring new growth opportunities for major market players operating in the global acetaminophen market.

Based on form, global acetaminophen market is bifurcated into tablet, liquid suspension, capsule, and other forms. Tablet form segment held largest market share in 2018 whereas liquid suspension segment is expected to register rapid CAGR over the forecast period.

Based on route of administration, global acetaminophen market is divided into oral, rectal and intravenous. The oral segment held major share of the market in 2018, however the rectal segment is likely to grow at high CAGR in the forecast period. Growing demand for over the counter and generic drugs is likely to drive the market for these segments. Besides, high population and availability of cheap oral paracetamols are other factors driving market growth of the oral acetaminophens.

Asia Pacific dominated the global acetaminophen market in 2018. Easy availability of over the counter acetaminophen, increasing chronic disease burden, increasing need to manage pain, growing awareness are factors driving the market in this region. India and China are largest markets in Asia Pacific for acetaminophen. North America was second largest regional market followed by Europe. Latin America is another highly growing regional market. Argentina and Brazil are expected to drive the acetaminophen market over the forecast period. Increasing healthcare spending and availability of affordable drugs are factors attributing to the rapid growth in Latin America. Middle East and Africa will see noticeable growth in the coming years with growth majorly focused in GCC countries and South Africa.

Major players included in the report are Genesis Biotech, M.M. Pharma, Aknil biotech, Arika healthcare, Captab biotech, and GlaxoSmithKline Pharmaceuticals Ltd. among others.

The report segment of global acetaminophen market as follows:

Global Acetaminophen (Paracetamol) Market: By Form

  • Capsule
  • Liquid Suspension
  • Tablet
  • Other Forms

Global Acetaminophen (Paracetamol) Market: By Route of Administration

  • Oral
  • Rectal
  • Intravenous

Global Acetaminophen (Paracetamol) Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Acetaminophen (Paracetamol) Market, 2016 - 2025, (USD Million)
    • 2.2. Acetaminophen (Paracetamol) Market: Snapshot
  • Chapter 3. Global Acetaminophen (Paracetamol) Market - Industry Analysis
    • 3.1. Acetaminophen (Paracetamol) Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases
      • 3.2.2. Increasing Demand for Pain Management Drugs
    • 3.3. Restraints
      • 3.3.1. High Competition
    • 3.4. Opportunity
      • 3.4.1. Emerging Markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by form segment
      • 3.6.2. Market attractiveness analysis by route of administration segment
      • 3.6.3. Market attractiveness analysis by regional segment
  • Chapter 4. Global Acetaminophen (Paracetamol) Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Acetaminophen (Paracetamol) Market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New form launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Acetaminophen (Paracetamol) Market - Form Segment Analysis
    • 5.1. Global Acetaminophen (Paracetamol) Market overview: by form
      • 5.1.1. Global Acetaminophen (Paracetamol) Market revenue share, by form, 2018 and 2025
    • 5.2. Capsule
      • 5.2.1. Global Acetaminophen (Paracetamol) Market by Capsule, 2016-2025 (USD Million)
    • 5.3. Liquid Suspension
      • 5.3.1. Global Acetaminophen (Paracetamol) Market by Liquid Suspension, 2016-2025 (USD Million)
    • 5.4. Tablet
      • 5.4.1. Global Acetaminophen (Paracetamol) Market by Tablet, 2016-2025 (USD Million)
    • 5.5. Other Forms
      • 5.5.1. Global Acetaminophen (Paracetamol) Market by Other Forms, 2016-2025 (USD Million)
  • Chapter 6. Global Acetaminophen (Paracetamol) Market - Route of Administration Segment Analysis
    • 6.1. Global Acetaminophen (Paracetamol) Market overview: by route of administration
      • 6.1.1. Global Acetaminophen (Paracetamol) Market revenue share, by route of administration, 2018 and 2025
    • 6.2. Oral
      • 6.2.1. Global Acetaminophen (Paracetamol) Market by Oral, 2016-2025 (USD Million)
    • 6.3. Rectal
      • 6.3.1. Global Acetaminophen (Paracetamol) Market by Rectal, 2016-2025 (USD Million)
    • 6.4. Intravenous
      • 6.4.1. Global Acetaminophen (Paracetamol) Market by Intravenous, 2016-2025 (USD Million)
  • Chapter 7. Global Acetaminophen (Paracetamol) Market - Regional Analysis
    • 7.1. Global Acetaminophen (Paracetamol) Market overview: by region
      • 7.1.1. Global Acetaminophen (Paracetamol) Market revenue share, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Acetaminophen (Paracetamol) Market, by country, 2016-2025 (USD Million)
      • 7.2.2. North America Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
      • 7.2.3. North America Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.2.4.2. The U.S. Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.2.5.2. Rest of North America Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Acetaminophen (Paracetamol) Market, by country, 2016-2025 (USD Million)
      • 7.3.2. Europe Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
      • 7.3.3. Europe Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.3.4. U.K.
        • 7.3.4.1. U.K. Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.3.4.2. U.K. Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.3.5.2. France Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.3.6.2. Germany Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.3.7.2. Rest of Europe Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Acetaminophen (Paracetamol) Market, by country, 2016-2025 (USD Million)
      • 7.4.2. Asia Pacific Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
      • 7.4.3. Asia Pacific Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.4.4.2. China Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.4.5.2. Japan Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.4.6.2. India Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Acetaminophen (Paracetamol) Market, by country, 2016-2025 (USD Million)
      • 7.5.2. Latin America Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
      • 7.5.3. Latin America Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.5.4.2. Brazil Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
        • 7.5.5.2. Rest of Latin America Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa Acetaminophen (Paracetamol) Market, 2016-2025 (USD Million)
      • 7.6.2. Middle East & Africa Acetaminophen (Paracetamol) Market revenue, by form, 2016-2025 (USD Million)
      • 7.6.3. Middle East & Africa Acetaminophen (Paracetamol) Market revenue, by route of administration, 2016-2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Genesis Biotech
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Form Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Aknil biotech
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Form Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. M.M. Pharma
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Form Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Arika healthcare
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Form Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Captab biotech
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Form Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. GlaxoSmithKline Pharmaceuticals Ltd.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Form Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social